Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Asthma rates are higher among Black people ... victory lap this spring to celebrate Medicare reforms, as well as inhaler cost caps secured by Sanders. Speaking in the Eisenhower Executive Office ...

Recent research reveals that anti-inflammatory inhalers not only cut the risk of severe asthma complications but also offer modest improvements in symptom control compared to traditional ...

The FTC believed Flovent's patent was "improperly or inaccurately listed," and this could "delay lower-cost generic drug ...

Private equity group CVC Capital Partners is on the hunt for a buyer for its majority stake in Italian pharmaceutical outsourcer Genetic Group, in a deal that they hope will value the business at ...

“This increase strains millions of families who rely on vital medications for asthma, tuberculosis, and more. Urging the ...

Expressing concern over the decision to hike prices of eight essential drugs by 50 per cent, the Congress on Saturday urged ...

In his letter to PM Modi, Tagore highlighted the strain this hike places on millions of families who rely on affordable medications for conditions like asthma, tuberculosis, and other chronic ...